MAPT and early-onset autosomal dominant Alzheimer disease: Plenty of evidence suggests that the accumulation of toxins like soluble amyloid-β (Aβ) and hyperphosphorylated tau cause dysfunction of synaptic plasticity and the simultaneous release of irregular neurotransmitters (NT) at synapses proceed to cognitive decline as seen in Alzheimer’s disease (AD).